Immediate Impact

17 by Nobel laureates 10 from Science/Nature 65 standout
Sub-graph 1 of 21

Citing Papers

Synthetic Glycans to Improve Current Glycoconjugate Vaccines and Fight Antimicrobial Resistance
2022 Standout
A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes
2022 StandoutScienceNobel
22 intermediate papers

Works of Alan S. Cross being referenced

Development of a broad spectrum glycoconjugate vaccine to prevent wound and disseminated infections with Klebsiella pneumoniae and Pseudomonas aeruginosa
2018
Desialylation of airway epithelial cells during influenza virus infection enhances pneumococcal adhesion via galectin binding
2015
and 19 more

Author Peers

Author Last Decade Papers Cites
Alan S. Cross 2995 2716 2487 215 8.7k
Joshua Fierer 2930 1992 2874 188 10.9k
Kazuhiro Tateda 1548 2354 2179 316 7.4k
Alice Prince 2924 5280 1739 150 11.7k
Reuben Ramphal 1150 3462 1525 133 8.5k
Paul G. Quie 4504 2640 2144 208 11.6k
M. P. Glauser 3615 1252 4183 154 11.5k
Keizo Yamaguchi 900 1843 1451 250 6.2k
Norbert Suttorp 4262 4687 4379 358 15.0k
Theodore J. Standiford 7145 4453 4067 234 17.1k
Shawn Skerrett 2011 1501 1552 93 5.4k

All Works

Loading papers...

Rankless by CCL
2026